You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
McKinsey
Merck
Harvard Business School
Medtronic

Last Updated: December 4, 2023

Zydus Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?

ZYDUS PHARMS has two hundred and sixty-five approved drugs.

There are twenty tentative approvals on ZYDUS PHARMS drugs.

Summary for Zydus Pharms
US Patents:0
Tradenames:232
Ingredients:223
NDAs:265

Drugs and US Patents for Zydus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms RIVASTIGMINE rivastigmine FILM, EXTENDED RELEASE;TRANSDERMAL 206318-002 Mar 4, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 206748-002 Feb 29, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 207340-003 Oct 31, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms Usa CLINDAMYCIN HYDROCHLORIDE clindamycin hydrochloride CAPSULE;ORAL 065217-002 Jan 31, 2005 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 203894-001 Mar 23, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 203553-008 Nov 16, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms AZELASTINE HYDROCHLORIDE azelastine hydrochloride SPRAY, METERED;NASAL 091409-001 Aug 14, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Injection 200 mcg/vial ➤ Subscribe 2015-05-01
➤ Subscribe for Injection 100 mcg/vial and 500 mcg/vial ➤ Subscribe 2015-04-14
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Boehringer Ingelheim
Colorcon
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.